PNEUMOVAX 23 sol inj ser pré 10 x 0.5 ml

7680656750042 CH-65675 J07AL01 08.08.

Reimbursement limitations:

0808 NEU

La prise en charge des coûts des vaccins au titre de mesure préventive dans le …

PNEUMOVAX 23 sol inj ser pré 10 x 0.5 ml
PNEUMOVAX 23 sol inj ser pré 10 x 0.5 ml
PNEUMOVAX 23 sol inj ser pré 10 x 0.5 ml
1 / 3
google

Details

Product number
6567501
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6B 25 µg, polysaccharida streptococci pneumoniae typus 7F 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9N 25 µg, polysaccharida streptococci pneumoniae typus 9V 25 µg, polysaccharida streptococci pneumoniae typus 10A 25 µg, polysaccharida streptococci pneumoniae typus 11A 25 µg, polysaccharida streptococci pneumoniae typus 12F 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15B 25 µg, polysaccharida streptococci pneumoniae typus 17F 25 µg, polysaccharida streptococci pneumoniae typus 20 25 µg, polysaccharida streptococci pneumoniae typus 22F 25 µg, polysaccharida streptococci pneumoniae typus 23F 25 µg, polysaccharida streptococci pneumoniae typus 33F 25 µg, natrii chloridum corresp. natrium 1.8 mg, phenolum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Pneumovax-23, Injektionslösung in einer Fertigspritze
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/01/2023
Professional SmPC
Français
20/01/2023
Professional SmPC
Italien
20/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.8 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
65675
Drug name
Pneumovax-23, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
J07AL01
Authorization status
Z
Dispensation category
B
First authorization
26/02/2016
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen, insbesondere Pneumonien, ab dem vollendeten 2. Lebensjahr

Packaging details

Description (FR)
PNEUMOVAX 23 sol inj 10 pce
Description (DE)
PNEUMOVAX 23 Inj Lös 10 Stk
Market launch
26/02/2016
Narcotic (BTM)
No

Other packaging sizes

PNEUMOVAX 23 sol inj 1 pce
1 FESP
View